In intensive care units, generic drugs save the lives of COVID-19 patients!

Of the 71 agents that may be needed to treat COVID-19 patients with severe progression, 69 are generic agents. So it's all about generics now!

To the article

We are committed!

For the industry

For the patients

For the policy makers

Our Agenda
leerer Blister
This really helps against shortages of supply!

This is how to improve the supply of medicines in Germany and strengthen Europe as a production location.

To the article

Our topics

Do you want to know what role generic medicines play in the German healthcare system, how important they are for patients - and what needs to be done for more security of supply? You can find these and more topics here!

More Information
Studien

Our studies

We at Pro Generika regularly commission scientific studies that deal with health policy and economic issues. Here you can find the most recent studies, all of which are available for download.

To the studies
YouTube Logo
Fact-Checking: Pharmaceutical Production in Europe

In this video, five professionals from the generics industry reveal the situation of the German and European pharmaceutical production and which measures could permanently stabilise supply chains that have become fragile.

To the film